Showing results (41-50 of 192) with videos related to
Sort By:
Pageof 20
Therapeutic Advances in Medical Oncology|February 1, 2018
Radiation effects on antitumor immune responses: current perspectives and challengesThomas Walle, Rafael Martinez Monge, Adelheid Cerwenka, et al.Cancer Research|July 19, 2011
Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2Sonja Textor, Nathalie Fiegler, Annette Arnold, et al.European Journal of Immunology|July 30, 2016
CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infectionAlexander Rölle, Anne Halenius, Eva-Maria Ewen, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilonNorman Nausch, Lore Florin, Bettina Hartenstein, et al.Journal for Immunotherapy of Cancer|July 2, 2024
IFNγ mediates the resistance of tumor cells to distinct NK cell subsetsTomáš Hofman, Siu Wang Ng, Irene Garcés-Lázaro, et al.The Journal of Experimental Medicine|November 30, 2005
Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejectionJohn M Routes, Sharon Ryan, Kristin Morris, et al.Arthritis Research & Therapy|September 15, 2016
Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cellsWolfgang Merkt, Maren Claus, Norbert Blank, et al.International Journal of Cancer|May 18, 2010
NF-κ B-dependent upregulation of ICAM-1 by HPV16-E6/E7 facilitates NK cell/target cell interactionSonja Textor, Rosita Accardi, Tereza Havlova, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2012
Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growthEva Schlecker, Ana Stojanovic, Christian Eisen, et al.Oncoimmunology|October 21, 2016
Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell helpJing Ni, Oliver Hölsken, Matthias Miller, et al.Pageof 20